Alligator Bioscience sells CD40 agonist antibody to Biossil

Alligator Bioscience has signed an agreement to sell all rights and assets related to the CD40 agonist antibody mitazalimab to Biossil.   Alligator will receive $750,000 upfront… Read More

3 November 2026 #Business & Investment #Cancer Research #News